SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Kyntra Bio, Inc. (KYNB) on Monday reported a loss of $15.2 million in its first quarter.
The San Francisco-based company said it had a loss of $3.76 per share. Losses, adjusted to account for discontinued operations, came to $3.74 per share.
The biotech drug developer posted revenue of $3.7 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KYNB at https://www.zacks.com/ap/KYNB
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
